Abstract
A golden retriever dog is described with total hexosaminid ase deficiency and raised GM2-ganglioside in CSF. The animal represents a model for human Sandhoff disease.
Similar content being viewed by others
REFERENCES
Gravel RA, Kaback MM, Proia RL, Sandhoff K, Suzuki K, Suzuki K (2000) The GM2 gangliosidosis. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3827-3876.
Ishikawa Y, Li SC, Wood PA, Li YT (1987) Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. J Neurochem 48: 860-864.
Singer HS, Cork LC (1989) Canine GM2 gangliosidosis: Morphological and biochemical analysis. Vet Pathol 26: 114-120.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamato, O., Matsuki, N., Satoh, H. et al. Sandhoff disease in a golden retriever dog. J Inherit Metab Dis 25, 319–320 (2002). https://doi.org/10.1023/A:1016562626961
Issue Date:
DOI: https://doi.org/10.1023/A:1016562626961